Post by Taiho Oncology, Inc.

At #ASCO26, our Chief Medical Officer, Harold Keer, MD, PhD, spoke with pharmaphorum editor in chief, Jonah Comstock, about Taiho’s latest milestones and ongoing efforts to develop breakthrough treatments for patients with cancer.​ Thank you, pharmaphorum, for the opportunity to speak about our next-generation cancer therapies and our commitment to making a difference in the lives of patients with cancer. ​ ​ Watch the conversation here: https://lnkd.in/gqdwVANb #ASCO #pharma